Ondansetron
Product Images NDC 67296-0341

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-0341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton4mg30s (Carton4mg30s)

Ondansetron Orally Disintegrating Tablets USP, 4 mg, in packaging label showing dose strength and usage instructions. The product is manufactured by Glenmark Pharmaceuticals Inc. The carton indicates the presence of 30 tablets divided into three blister cards with 10 tablets each. Instructions for removing tablets from the blister pack are illustrated on the side panel.*

FDA Label Image

Carton8mg10s (Carton8mg10s)

Ondansetron Orally Disintegrating Tablets, USP 8 mg packaging label from Glenmark Pharmaceuticals Inc., containing 10 tablets in one blister card. The label includes storage instructions, a warning for phenylketonurics, and detailed illustrated instructions for removing and taking the tablets without pushing them through the foil. Manufactured for Glenmark Pharmaceuticals Inc., USA, and marked as Rx only.*

FDA Label Image

Image-01 (Image 01)

Ondansetron Tablets USP 4 mg packaging label from Glenmark Pharmaceuticals, containing 30 tablets. The label includes drug information, storage instructions, manufacturer details for Glenmark Pharmaceuticals Inc., Mahwah, NJ, and indicates the product is made in India. The NDC on the label is 68462-105-30.*

FDA Label Image

Image-02 (Image 02)

Ondansetron Tablets, USP 8 mg in a package of 30 tablets. The label includes dosage and storage information, manufacturer details naming Glenmark Pharmaceuticals, Inc. USA, and specifies 'Rx only' status. The product is dispensed in a light-resistant container and is marked with NDC 68462-106-30.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of the active ingredient Ondansetron. The diagram shows the molecular framework including aromatic rings, nitrogen atoms, and functional groups characteristic of Ondansetron.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate showing the molecular arrangement with indole and imidazole rings, a ketone group, and associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.